The global pharmaceutical industry is said to be a huge and growing market in the world.
We are a stem cell bio-venture company conducting research and development that has never been done before.
Our project was selected as a grant project. Grants name：FY2024 “Small and Medium Enterprise Management Reform Support Project” Theme：Development of oligodendrocyte progenitor cells and culture media for commercial research Issuing authority：KYOTO Industrial Support Organization 21
Grants
Our representative participated in the “KLSAP2023 Pitch Event” held at Creative Lab Kobe on July 14, 2023, and spoke at the “Pitch Competition”.
Events
On October 31, 2022, we signed a joint research agreement with Mochida Pharmaceutical Co. Ltd. In this joint research, we will combine our stem cell technology with Mochida’s scaffold material (biomaterials) technology to develop better regenerative medicine products.
Collaboration/Partnership
On November 1, 2021, the company raised funds through crowdfunded subscription rights.
Funding
Our project was selected as a grant project. Grants name：FY2021 “Next Generation Regional Industry Promotion Project” Theme：Efficacy of human neural stem cell “OligoGenie” in the treatment of Alzheimer’s disease. Issuing authority：KYOTO Industrial Support Organization 21
Grants
Our project was selected as a grant project. Grants name：FY2021 “Startups Solving Social Issues” Theme：Establishment of a Master Cell Bank Production Method for Human Neural Stem Cells for Clinical Trials Issuing authority：Advanced Science, Technology & Management Research Institute of KYOTO (ASTEM)
Grants
